Aevis Victoria Aktie

Aevis Victoria AAQS 2024

Aevis Victoria AAQS

3

Ticker

AEVS.SW

ISIN

CH0478634105

WKN

A2PLW7

Aevis Victoria har en aktuel AAQS på 3. En høj AAQS kan betragtes som et positivt tegn på, at virksomheden udvikler sig succesfuldt. Investorerne kan forvente, at virksomheden er på rette spor mod at skabe overskud. På den anden side er det vigtigt at betragte AAQS for aktien Aevis Victoria i forhold til de opnåede overskud og sammenligne med andre virksomheder i samme branche. En høj AAQS er ikke en absolut garanti for en positiv fremtid. Det er kun på den måde, man kan få et komplet billede af virksomhedens præstationer. For bedre at kunne vurdere virksomhedens udvikling er det vigtigt at betragte AAQS i sammenligning med andre virksomheder i samme branche. Generelt bør investorer altid betragte en virksomheds AAQS i sammenhæng med andre nøgletal som overskud, EBIT, cash flow og andre for at træffe en velbaseret investeringsbeslutning.

Aevis Victoria Aktienanalyse

Hvad gør Aevis Victoria?

Aevis Victoria SA is a Swiss company headquartered in Geneva. It was founded in 2006 and has developed a wide range of services over the years through strategic decisions and acquisitions. The history of Aevis Victoria began with the acquisition of three private clinics by founder Antoine Hubert. In 2007, the company started working on its first project, the Genolier Swiss Medical Network, a network of private clinics in Switzerland and France. Aevis Victoria has since made several other acquisitions, including a majority stake in Victoria-Jungfrau Collection AG, a renowned hotel group in Switzerland. Aevis Victoria's business model is based on investing in companies operating in the fields of healthcare, wellness, and lifestyle. The company offers a wide range of services including private clinics, spa and wellness centers, hotel and property management, and innovative technology and software for the healthcare and tourism industries. Among Aevis Victoria's various divisions, the Genolier Swiss Medical Network is the centerpiece. The network's clinics offer a comprehensive range of services including general medicine, surgery, obstetrics and gynecology, cardiology, neurology, and oncology. The network specializes in treating international patients and is globally recognized for its high quality medical care and sophisticated infrastructure. Aevis Victoria is also active in the field of spa and wellness centers. The group owns and operates several luxury wellness resorts, including the Victoria Jungfrau Grand Hotel & Spa in Interlaken and the La Réserve Genève Hotel & Spa in Geneva. These properties are equipped to the highest standards and offer a wide range of wellness and spa services tailored to the needs of discerning customers. In the hotel and property management sector, Aevis Victoria is a major player in the Swiss market and operates several prestigious hotels. In addition to Victoria-Jungfrau Collection AG, the group also owns the Carlton Hotel St. Moritz and the Hotel Royal Savoy Lausanne. When developing and implementing new real estate projects, Aevis Victoria places great importance on sustainability, quality, and innovation. Aevis Victoria also invests in innovative technologies and software for the healthcare and tourism industries. The company has previously financed several start-ups involved in the development of medical devices and digital platforms for the healthcare sector. The focus is on improving medical care and the patient experience. In summary, Aevis Victoria is a significant Swiss company in the field of healthcare, wellness, and lifestyle. The company's wide range of services, closely linked to its vision of high quality and innovation, is exemplary. Aevis Victoria will continue to invest in new technologies and services to expand its offerings and strengthen its position in these growing markets. Aevis Victoria ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Ofte stillede spørgsmål om Aevis Victoria aktien

Aktiespareplaner tilbyder en attraktiv mulighed for investorer at opbygge formue på lang sigt. En af de største fordele er den såkaldte cost-average-effekt: Ved regelmæssigt at investere et fast beløb i aktier eller aktiefonde, køber man automatisk flere andele, når priserne er lave, og færre, når de er høje. Dette kan føre til en mere fordelagtig gennemsnitspris per andel over tid. Desuden giver aktiespareplaner også småinvestorer adgang til dyre aktier, da de kan deltage med små beløb. Den regelmæssige investering fremmer også en disciplineret investeringsstrategi og hjælper med at undgå følelsesladede beslutninger, som impulsiv køb eller salg. Derudover drager investorer fordel af den potentielle værdistigning af aktierne samt af udbytteudlodninger, der kan geninvesteres, hvilket forstærker renters rente effekten og dermed væksten af det investerede kapital.

Andere Kennzahlen von Aevis Victoria

Vores aktieanalyse af Aevis Victoria Omsætning-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Aevis Victoria Omsætning. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: